DK1185255T3 - Retinaprotektive oftalmologiske lægemidler indeholdende ramipril eller ramiprilat - Google Patents

Retinaprotektive oftalmologiske lægemidler indeholdende ramipril eller ramiprilat

Info

Publication number
DK1185255T3
DK1185255T3 DK00951603T DK00951603T DK1185255T3 DK 1185255 T3 DK1185255 T3 DK 1185255T3 DK 00951603 T DK00951603 T DK 00951603T DK 00951603 T DK00951603 T DK 00951603T DK 1185255 T3 DK1185255 T3 DK 1185255T3
Authority
DK
Denmark
Prior art keywords
ramiprilat
medicine
visual
acuity
ramipril
Prior art date
Application number
DK00951603T
Other languages
English (en)
Inventor
Raouf Rekik
Original Assignee
Rekik Elyes Ben Mohamed Raouf
Raouf Rekik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9915359A external-priority patent/FR2794975A1/fr
Application filed by Rekik Elyes Ben Mohamed Raouf, Raouf Rekik filed Critical Rekik Elyes Ben Mohamed Raouf
Application granted granted Critical
Publication of DK1185255T3 publication Critical patent/DK1185255T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DK00951603T 1999-06-16 2000-06-16 Retinaprotektive oftalmologiske lægemidler indeholdende ramipril eller ramiprilat DK1185255T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TN99122 1999-06-16
FR9915359A FR2794975A1 (fr) 1999-06-16 1999-12-06 Medicaments opthalmologiques neuro et retino-protecteurs
PCT/FR2000/001679 WO2000076499A2 (fr) 1999-06-16 2000-06-16 Medicaments ophtalmologiques neuro-et retino-protecteurs

Publications (1)

Publication Number Publication Date
DK1185255T3 true DK1185255T3 (da) 2009-07-06

Family

ID=26235177

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00951603T DK1185255T3 (da) 1999-06-16 2000-06-16 Retinaprotektive oftalmologiske lægemidler indeholdende ramipril eller ramiprilat

Country Status (20)

Country Link
US (1) US7049340B1 (da)
EP (1) EP1185255B1 (da)
JP (1) JP2003501461A (da)
AT (1) ATE424819T1 (da)
AU (1) AU6449000A (da)
BR (1) BR0011714A (da)
CA (1) CA2376909A1 (da)
CZ (1) CZ20014516A3 (da)
DE (1) DE60041765D1 (da)
DK (1) DK1185255T3 (da)
ES (1) ES2324200T3 (da)
HU (1) HUP0201478A3 (da)
MA (1) MA26798A1 (da)
MX (1) MXPA01012907A (da)
NO (1) NO20016088L (da)
PL (1) PL352365A1 (da)
SI (1) SI1185255T1 (da)
SK (1) SK18772001A3 (da)
TR (1) TR200103665T2 (da)
WO (1) WO2000076499A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826276A1 (fr) * 2001-06-20 2002-12-27 Raouf Rekik Administration des inhibiteurs de l'enzyme de conversion de l'angiotensine dans les degradations visuelles des sujets ages dues a la presbytie
US7858611B2 (en) 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2382975A3 (en) * 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
TNSN08110A1 (en) * 2008-03-11 2009-07-14 Rekik Raouf Dr Drug delivery to the anterior and posterior segment of the eye from drops
TN2010000566A1 (en) * 2010-12-03 2012-05-24 Rekik Raouf Folic acid - ramipril combination : cell protective neuroprotective and retinoprotective ophtalmologic drugs
RU2471454C2 (ru) * 2010-12-14 2013-01-10 Валерий Викторович Педдер Способ лечения дистрофических заболеваний сетчатки глаза
JP6238977B2 (ja) * 2012-06-29 2017-11-29 ラオフ・レキク 視神経症または先天性視神経萎縮を治療するためのアンギオテンシン変換酵素阻害薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3381850D1 (de) * 1982-12-27 1990-10-04 Schering Corp Pharmazeutische zusammensetzung.
DE3410732A1 (de) * 1984-03-23 1985-09-26 Hoechst Ag, 6230 Frankfurt Methode zur behandlung des glaukoms
US4656188A (en) * 1985-10-09 1987-04-07 Merck & Co., Inc. Ace inhibitors in macular degeneration
JPH05306296A (ja) * 1992-04-24 1993-11-19 Marino Forum 21 魚類由来ペプチドとその製法
AU2089099A (en) * 1998-01-16 1999-08-02 Alcon Laboratories, Inc. Topical administration of angiotensin-converting enzyme inhibitors

Also Published As

Publication number Publication date
HUP0201478A3 (en) 2004-05-28
US7049340B1 (en) 2006-05-23
ATE424819T1 (de) 2009-03-15
CZ20014516A3 (cs) 2002-05-15
SK18772001A3 (sk) 2002-04-04
WO2000076499A2 (fr) 2000-12-21
HUP0201478A2 (hu) 2002-11-28
EP1185255A2 (fr) 2002-03-13
CA2376909A1 (fr) 2000-12-21
MA26798A1 (fr) 2004-12-20
NO20016088D0 (no) 2001-12-13
JP2003501461A (ja) 2003-01-14
BR0011714A (pt) 2002-03-05
WO2000076499A3 (fr) 2001-05-17
ES2324200T3 (es) 2009-08-03
EP1185255B1 (fr) 2009-03-11
MXPA01012907A (es) 2003-06-24
PL352365A1 (en) 2003-08-25
SI1185255T1 (sl) 2009-08-31
TR200103665T2 (tr) 2002-10-21
DE60041765D1 (de) 2009-04-23
AU6449000A (en) 2001-01-02
NO20016088L (no) 2002-02-12

Similar Documents

Publication Publication Date Title
Verbraeken et al. Posttraumatic endophthalmitis
EP1074258A3 (en) Methods and compositions for treating diseases and conditions of the eye
DK1185255T3 (da) Retinaprotektive oftalmologiske lægemidler indeholdende ramipril eller ramiprilat
Quah et al. A Review of 5 Years' Experience in the Use of Botulinum Toxin A in the Treatment of Sixth Cranial Nerve Palsy at Singapore National Eye Centre
AU6069794A (en) Method and compositions for noninvasive dose to effect administration of lipophilic drugs
DK0410749T3 (da) Anthocyanidiner til behandling af ophthalmiske sygdomme
RU2148972C1 (ru) Способ лечения гемофтальма
AU2001223953A1 (en) Use of l-carnitine as stabilizing agent of proteins
RU2077877C1 (ru) Способ лечения сосудистой патологии глаз
DE69431430D1 (de) Faktor XIII zur Behandlung von Hautwunden
HUP0301451A2 (hu) CGMP PDE5 inhibitorok alkalmazása perifériás érbetegségek, perifériás neuropátiák és autonóm neuropátiák kezelésére szolgáló gyógyszerkészítmények elżállítására
US9545409B2 (en) Use of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof in pharmaceutical compositions as a neuroretinal protector
Schiemann et al. Coincidence of cytomegalovirus retinitis and central retinal vein occlusion in a patient with hemophilia B and AIDS
CY1110476T1 (el) Οφθαλμολογικα φαρμακα προστατευτικα του αμφιβληστροειδους τα οποια περιεχουν ραμιπριλη ή ραμιπριλατη
Balasubaramaniam et al. Purtscher's Retinopathy After Cardiopulmonary Resuscitation: A Literature Review
RU2290191C2 (ru) Способ лечения туберкулезных увеитов
Kubota et al. Erg of Behçet’s Disease and Its Diagnostic Significance
SU1482694A1 (ru) Способ лечени компенсированной первичной открытоугольной глаукомы
Goldberg Comparison of tropical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J. Glaucoma 2001; 10: 414-22
RU2160076C2 (ru) Способ хирургической коррекции миопии и миопического астигматизма высокой степени
Roberts Antifibrinolytic agents in traumatic hemorrhage
Deutsch et al. Thomas, C., Cordier, J. and Algan, B. Retinal vascular lesions of richettsial ori-gin. Bull. et. mem. Sot. franc. d’opht. 72: 621-634, 1959. The etiological survey of diverse eye dis
RU94024966A (ru) Средство для улучшения процессов микроциркуляции и коррекции иммуногемостатических нарушений при лечении глазных заболеваний
KOO et al. Clinical Study of Traumatic Hyphema
WO2007036920A3 (en) Therapeutic use of polyanhydroglucronic acid